Healthy Infants
36
6
8
20
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.8%
1 terminated out of 36 trials
95.2%
+8.7% vs benchmark
22%
8 trials in Phase 3/4
0%
0 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (36)
Efficacy of a Dietary Supplement in Infants
An Intervention Study in Healthy Infants Aged 0-6 Months With Probiotics Lacticaseibacillus Rhamnosus LRa05 (LRa05) and Bifidobacterium Animalis Subsp. Lactis BLa80 (BLa80) vs. Placebo, for Promoting Gut Microbiome Development.
The Trial of a New Infant Formula in Healthy Term Chinese Infants
Preventive Effect of a Dietary Supplement With Two Probiotic Limosilactobacillus Reuteri Strains on Excessive Crying and Colic in Healthy Newborns.
Measurement of in Vivo Mitochondrial Capacity in Infants
Starter Infant Formula With Synbiotics
Efficacy of Two HMOs in Chinese Infants
Efficacy of a New Infant Formula Composition on Gut Health in Infants
Probiotic for Infants
Maternal High Fibre Fermented Diet Effect on Breastfed Infant Gut Microbiome
Characterization of the Gastrointestinal Microbiota in Newborn Infants
HMOs on Infant Gut Microbiota Modulation and Development of the Immune System in Healthy Infants
Comparative Effects of A2 Platinum Stage 1 Infant Formula on Infant Digestion and Comfort
Safety and Efficacy of Infant Formulas Supplemented With Pre- and Probiotic(s)
Infant Feeding Practice and Gut Comfort Study
Second Generation Human Milk Oligosaccharides Blend Study
To Investigate Effects of a New Infant Formula in Healthy Term Chinese Infants
Impact of Infant Formula on Caregiver-perceived Intolerance
Effects of Different ARA Formulations of Infant Formula on Fatty Acid Status, Immune Markers and Infection Rates in Infants
Influence of Inflammation on Micronutrient Status Assessment